6 completed, 1 recruiting, 1 unknown. 3 Phase 1, 2 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Not applicable | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Myocardial Failure: new trials by email Literature Review of Myocardial Failure trials Research Report on Myocardial Failure
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Social Prescribing to Improve Adherence and Outcomes in Women With Heart Failure Social prescribing - Heart Failure, Cardiac Failure | Not applicable | Recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | 200 | 2025-10-23 | 2026-02-20 |
| The Usefulness of Myocardial Work IndeX in ExtraCorporeal Membrane Oxygenation Patients Echocardiography, Mechanical Circulatory Support | Unknown | Semmelweis University Heart and Vascular Center | 100 | 2024-06-01 | 2024-04-18 | |
| Evaluating the Adherence Improving Self-Management Strategy Intervention in Chronic Heart Failure Patients Adherence Improving self-Management Strategy, Treatment-as-usual - Chronic Heart Failure, Heart Decompensation | Not applicable | Completed | Radboud University Medical Center | 86 | 2020-12-14 | 2023-06-15 |
| Monitoring Drug-induced Myocarditis (CardiTOX) Drug inducing myocarditis - Myocarditis, Myocardial Failure | Completed | Groupe Hospitalier Pitie-Salpetriere | 6000 | 2019-04-09 | 2023-04-05 | |
| An Investigational Study of Continuous 8-Hour Intravenous Administrations of BMS-986231 in Participants With Heart Failure and Reduced Heart Function Given a Standard Dose of Loop Diuretic BMS-986231, Furosemide, Placebo - Cardiac Failure, Myocardial Failure | Phase 2 | Completed | Bristol-Myers Squibb | 23 | 2019-01-17 | 2021-02-26 |
| An Investigational Study to Evaluate Experimental Medication BMS-986224 in Renally Impaired Participants BMS-986224 - Cardiac Failure, Myocardial Failure | Phase 1 | Completed | Bristol-Myers Squibb | 50 | 2018-08-14 | 2020-02-25 |
| An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function BMS-986231 - Liver Dysfunction, Liver Insufficiency | Phase 1 | Completed | Bristol-Myers Squibb | 76 | 2018-05-25 | 2020-08-27 |
| A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function BMS-986231 - Myocardial Failure, Cardiac Failure | Phase 1 | Completed | Bristol-Myers Squibb | 48 | 2018-03-15 | 2019-09-11 |
Heart Failure (8) · Coitus (1) · Hepatic Insufficiency (1) · Liver Diseases (1) · Liver Failure (1) · Medication Adherence (1) · Motor Activity (1) · Myocarditis (1) · Renal Insufficiency (1) · Shock, Cardiogenic (1)
Cardiovascular Diseases (8) · Heart Diseases (8) · Behavior (2) · Cardiomyopathies (1) · Digestive System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Health Behavior (1) · Infarction (1) · Ischemia (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Necrosis (1)
Furosemide (1)
Bristol-Myers Squibb (4) · Groupe Hospitalier Pitie-Salpetriere (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Radboud University Medical Center (1) · Semmelweis University Heart and Vascular Center (1)
Hungary (2) · Poland (2) · Canada (1) · Czechia (1) · France (1) · Netherlands (1) · United Kingdom (1) · United States (1)
Marijn de Bruin, prof. dr. (1)
2017 (1), 2018 (1), 2025 (1)